Polar Pharma India (Delisted) share price history
BSE: 523333
Last traded ₹0.82 on 17 Sep 2013
Delisted on 5 Mar 2018.
Last announcements
The company's own last announcements before its shares stopped trading, routine notices left out.Share news and announcements
Jan 2013
1 Jan · Change in Office Address
Company is shifting to the following address with effect from January 01, 2013 :- Polar Pharma India Limited 18, Rabindra Sarani ....
Dec 2012
17 Dec · Updates
Company has participated in the annual tender for procurement of male condoms floated by Ministry of Health & Family Welfare (MHFW), Govt. ....
Nov 2012
Oct 2012
Sep 2012
5 Sep · Meeting
Register of Members & Share Transfer Books of the Company will remain closed from September 24, 2012 to September 29, 2012 (both days inclusive) ....
Aug 2012
Results
Standalone, as consolidated accounts are on record for only 1 of the last ten years; ₹ crore, the charts by years to March, the table by quarter. No standalone results on record for the years to Mar 2009 and Mar 2011.Quarterly results
Quarter to Sep 2012, against the quarter before
- Revenue
- –
- Net profitNet profit. Under it, net profit in the quarter before. A change in per cent is not worked out where either period is a loss or nothing.
- −₹5.84 CrQuarter to Jun 2012: −₹5.85 Cr
Revenue by year
Peak revenue ₹26 Cr, year to Mar 2008
Net profit by year, a loss in red
- Net profit
- Loss
A loss in 3 of the 3 years with results on record
| ₹ crore | Dec 2010 | Mar 2011 | Jun 2011 | Sep 2011 | Dec 2011 | Mar 2012 | Jun 2012 | Sep 2012 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 4.14 | 6.67 | 3.54 | 3.23 | 4.04 | 5.46 | 0.01 | – |
| Net profit | −1.81 | −3.79 | −5.21 | −4.24 | −3.52 | −5.16 | −5.85 | −5.84 |
| Net marginNet margin. Net profit as a percentage of revenue: how much of each rupee of sales is left after every cost, interest and tax. | −43.7% | −56.9% | −147.2% | −131.0% | −87.1% | −94.5% | −97,550.0% | – |
Standalone. The last eight quarters. The latest is shaded.
Where the return came from
Yearly rates to Mar 2012, per-share figures restated for splits and bonuses.
| Over | Return a year | Earnings growth | Change in P/E | Dividend yield |
|---|---|---|---|---|
| 1 year | −18.9% | – | – | 0.0% |
| 3 years | −5.1% | – | – | 0.0% |
| 5 years | −31.4% | – | – | 0.0% |
Return is price growth plus the average dividend yield. Change in P/E is (1 + price growth) / (1 + earnings growth) - 1, so the parts compound rather than add. Earnings growth and the change in P/E are left empty where earnings per share at either end of the window was a loss or is not on record.
Recent sessions
The last 10 trading days to 17 Sep 2013, as traded on BSE.
| Date | Open | High | Low | Close | Average price | Volume |
|---|---|---|---|---|---|---|
| 17 Sep 2013 | 0.82 | 0.82 | 0.82 | 0.82 | 0.82 | 540 |
| 12 Sep 2013 | 0.86 | 0.86 | 0.86 | 0.86 | 0.86 | 941 |
| 11 Sep 2013 | 0.95 | 0.95 | 0.90 | 0.90 | 0.94 | 4,000 |
| 10 Sep 2013 | 0.94 | 0.94 | 0.94 | 0.94 | 0.94 | 10 |
| 5 Sep 2013 | 0.90 | 0.90 | 0.82 | 0.90 | 0.82 | 510 |
| 4 Sep 2013 | 0.86 | 0.86 | 0.86 | 0.86 | 0.86 | 315 |
| 3 Sep 2013 | 0.82 | 0.82 | 0.82 | 0.82 | 0.82 | 10 |
| 2 Sep 2013 | 0.79 | 0.79 | 0.79 | 0.79 | 0.79 | 3,606 |
| 30 Aug 2013 | 0.83 | 0.83 | 0.83 | 0.83 | 0.83 | 400 |
| 29 Aug 2013 | 0.87 | 0.87 | 0.87 | 0.87 | 0.87 | 400 |
Prices in ₹ per share as traded, not adjusted.
Company details
- Legal name
- Polar Pharma India Ltd.
- BSE code
- 523333
- ISIN
- INE145D01019
- Face value
- ₹10
- CIN
- L25199OR1988PLC002144
- Corporate identity number, the registrar of companies' code for it